Title : Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.

Pub. Date : 2021 Sep

PMID : 34114066






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: Comedications may be the cause for this inter-occasion variation in bioactivation of cyclophosphamide and the ensuing phenoconversion may account for the conflicting reports in the literature about the relationship between CYP2C19 genotype and CP bioactivation pharmacokinetics. Cyclophosphamide cytochrome P450 family 2 subfamily C member 19 Homo sapiens